A Study of KL590586 in Patients With Advanced Solid Tumors
Clinical trial NCT05265091 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05265091
- Sponsor
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-15
- Primary completion
- 2026-12-31
- Enrollment
- 414
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.